War on Science
Chilling New Attacks on Scientific Integrity
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-10Apr 21, 2025
Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17Mar 12, 2025
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4Jan 24, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07Nov 09, 2023
Recombinant Proteins
The Expanding Role for Recombinant Proteins in Research
Rob Burgess, Ph.D.
Sino Biological
PAO-11-22-PATV-01Jan 06, 2023
Mental Health
Mental Health During a Global Pandemic
Marc Technow
Nice Insight
PAO-06-022--NI-03Jun 24, 2022
COVID-19 Breathalyzer Diagnostic
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
U.S. Food & Drug Administration
PR-M04-22-09Apr 14, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05Mar 18, 2022
Remote Auditing
Will Remote Pharma GMP Auditing Continue Post-COVID?
Alasdair Leckie
PAO-02-022-CL-21Mar 16, 2022
Antibody Therapeutics
Developing New Antibody Therapeutics for COVID-19 and Beyond
Ian Chan
Abpro
PAO-01-22-CL-01Mar 12, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04Mar 12, 2022
COVID-19 Prevention
AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19
AstraZeneca Canada
PR-M02-22-21Feb 23, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05Feb 08, 2022
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
Brand Institute
PR-M02-22-01Feb 01, 2022
COVID-19 Research
MU Study Identifies Mutations Specific to Omicron Variant
University of Missouri
PR-M01-22-17Jan 25, 2022
Data Connectivity
Discussing the Advancements in Oncology
Tim Roberts
PCI Pharma Services
PATV-12-21-01Jan 19, 2022
Immunotherapy
Immune Biosolutions Reports That Its Lead Immunotherapy Product IBIO123 Neutralizes 100% of the SARS-CoV-2 Variants of Concern (VOCs), Including Omicron
Immune Biosolutions
PR-M01-22-06Jan 10, 2022
Thermal Packaging
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine
Thermal Custom Packaging
PR-M01-22-02Jan 04, 2022
Cell Therapy
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
Ashish Patel, Ph.D.
The National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC)
PAO-09-21-CL-13Sep 29, 2021
COVID19 Nasal Spray
pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2
pHOXBIO
PR-M09-21-07Sep 24, 2021